Structure-based analysis and biological characterization of imatinib derivatives reveal insights towards the inhibition of wild-type BCR-ABL and its mutants-Reference-Cited by-同舟云学术

Structure-based analysis and biological characterization of imatinib derivatives reveal insights towards the inhibition of wild-type BCR-ABL and its mutants

Published:2019-12 Issue:24 Volume:29 Page:126758
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Yang Minjian,Xi Qiumu,Jia Wenqiang,Wang Xiaojian^ORCID

Funder

CAMS Collaborative Innovation Project

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference19 articles.

1. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia;Ren;Nat Rev Cancer,2005

2. Chronic myeloid leukemia;Sawyers;N Engl J Med,1999

3. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

4. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview;Baccarani;Leukemia,2019

5. Activity of a specific inhibitior of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome;Druker;N Engl J Med,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic myeloid leukemia in the chronic phase: A real-world single-center retrospective study, with a focus on premature drug discontinuation;Leukemia Research;2024-07

2. Philadelphia chromosome-positive acute myeloid leukemia successfully treated by allogeneic hematopoietic stem cell transplantation: A case report and review of the literature;Medicine;2024-05-10

3. Clinical efficacy and safety of flumatinib versus dasatinib combined with multi-drug chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia;Hematology, Transfusion and Cell Therapy;2024-02

4. High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability;OncoTargets and Therapy;2023-10

5. Basic and clinical study of efficacy and adverse effects of flumatinib in Ph+ ALL;Frontiers in Pharmacology;2023-05-05